SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Suven exhibiting portfolio of investigational neuroscience NCEs at AAIC

23 Jul 2018 Evaluate

Suven Life Science is exhibiting and presenting several exciting new results and data presentations from Suven’s portfolio of investigational Neuroscience New Chemical Entities (NCEs) which has being presented at Alzheimer's Association International Conference (AAIC) being held in Chicago, USA starting July 22 to 26, 2018.

Alzheimer’s disease is one of the scourges of modern day health care. Alzheimer’s is not just a memory loss as everyone thinks but Alzheimer’s kills. Current Alzheimer's treatments cannot stop Alzheimer's from progressing, they can temporarily slow the worsening of dementia symptoms and improve quality of life.

There is a worldwide effort under way to find better ways to treat the disease, delay its onset and prevent it from developing and this is where Suven is focusing on developing drugs for the treatment of this debilitating disease. Suven has excellent portfolio of new molecules through 4 mechanisms of action using 5-HT6, 5-HT4, H3 receptors and M1PAM for the symptomatic treatment of cognitive impairment in Alzheimer’s disease but also possibly useful in reducing the disease progression.

Suven Life Sciences Share Price

195.90 -0.10 (-0.05%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×